Literature DB >> 3102132

Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis.

Y Shoenfeld, Y Vilner, A R Coates, J Rauch, G Lavie, D Shaul, J Pinkhas.   

Abstract

Classical models of experimental autoimmune diseases, such as adjuvant arthritis entail the use of mycobacteria. Furthermore, BCG immunotherapy may be followed by arthritic symptoms. To test the infection-autoimmunity relationship of mycobacteria, we used monoclonal antibodies raised against M. tuberculosis and against DNA. Murine monoclonal anti-TB antibodies were found to react with ssDNA, dsDNA and other polynucleotides. Monoclonal anti-DNA autoantibodies derived from patients and mice with SLE bound to three glycolipids shared among all mycobacteria and derived from mycobacterial cell wall. Prior incubation of the antibodies with ssDNA and other polynucleotides or with glycolipid antigens inhibited binding. These results indicate that infecting mycobacteria share antigens with human tissue, thus accounting in part for the production of autoantibodies in mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3102132      PMCID: PMC1542527     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies.

Authors:  A R Coates; J Hewitt; B W Allen; J Ivanyi; D A Mitchison
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

2.  Transient autoimmune hemolytic anemia and pulmonary tuberculosis.

Authors:  H W Murray
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

3.  Molecular recognition and the future of monoclonal antibodies.

Authors:  D Lane; H Koprowski
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

4.  Hybridoma autoantibodies to DNA.

Authors:  C Andrzejewski; B D Stollar; T M Lalor; R S Schwartz
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica.

Authors:  M Weiss; S H Ingbar; S Winblad; D L Kasper
Journal:  Science       Date:  1983-03-18       Impact factor: 47.728

6.  Microbial parasitism cross-reactive with host antigen: implications concerning loss of "self" tolerance and development of autoimmune disease.

Authors:  P Y Paterson
Journal:  Recomb DNA Tech Bull       Date:  1981-09

7.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

8.  Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.

Authors:  W van Eden; J Holoshitz; Z Nevo; A Frenkel; A Klajman; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Purification of serologically active phosphoinositides of Mycobacterium tuberculosis.

Authors:  M C Pangborn; J A McKinney
Journal:  J Lipid Res       Date:  1966-09       Impact factor: 5.922

10.  Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues.

Authors:  M V Haspel; T Onodera; B S Prabhakar; M Horita; H Suzuki; A L Notkins
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

View more
  26 in total

Review 1.  Autoantibodies and antibacterial antibodies: from both sides now.

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

Review 2.  Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review.

Authors:  Elisa Tinazzi; Vincenzo Ficarra; Sara Simeoni; Walter Artibani; Claudio Lunardi
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

Review 3.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.

Authors:  G Bothamley; J S Beck; W Britton; A Elsaghier; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

5.  Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.

Authors:  Yinon Shapira; Bat-Sheva Poratkatz; Boris Gilburd; Ori Barzilai; Maya Ram; Miri Blank; Staffan Lindeberg; Johan Frostegård; Juan-Manuel Anaya; Nicola Bizzaro; Luis J Jara; Jan Damoiseaux; Yehuda Shoenfeld; Nancy Agmon Levin
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 6.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

7.  Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis.

Authors:  César Rodríguez-Narciso; Mayra Pérez-Tapia; Rosa María Rangel-Cano; Celio L Silva; Mariana Meckes-Fisher; Rafael Salgado-Garciglia; Sergio Estrada-Parra; Rodolfo López-Gómez; Iris Estrada-García
Journal:  Transgenic Res       Date:  2010-06-06       Impact factor: 2.788

8.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

9.  Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.

Authors:  M Sutjita; A Hohmann; R Comacchio; J Bradley
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 10.  Pathogenic anti-DNA idiotype (16/6 Id) in systemic lupus erythematosus.

Authors:  Y Shoenfeld; E Mozes
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.